图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
真核基因表达评论综述™
影响因子: 1.841 5年影响因子: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN 打印: 1045-4403
ISSN 在线: 2162-6502

真核基因表达评论综述™

DOI: 10.1615/CritRevEukaryotGeneExpr.2017018935
pages 53-62

Applications of Three-Dimensional Cell Cultures in the Early Stages of Drug Discovery, Focusing on Gene Expressions, Drug Metabolism, and Susceptibility

Maddaly Ravi
Department of Human Genetics, Faculty of Biomedical Sciences, Technology, and Research, Sri Ramachandra University, Porur, Chennai 600116, India

ABSTRACT

Three-dimensional (3D) cell cultures represent advances in the way in which cells are grown in vitro, and they are gaining ground for a variety of applications. Advantages of 3D systems include reliable and realistic study endpoints. Cells grown in 3D conditions mimic in vivo conditions to an extent that is not possible with traditional 2D cell-culture methods. One major area in which 3D cell cultures have proven to make a difference is with drug discovery. The facets taken advantage of for drug discovery are the cells' complex microenvironment, including the production of extracellular matrices, altered gene expressions and their protein products, drug metabolism, and susceptibility to drugs when compared to 2D cultures. Altered protein and gene expressions are useful for drug-target identification. The susceptibility of 3D cultured cells for drug-induced effects can be used to obtain realistic data in a dose-dependent manner that can aid in identifying effective drug dosage. This review presents the contributions of 3D cell cultures for drug discovery, taking into consideration gene and protein expressions, drug metabolism, and susceptibility to drugs as the major focus points.


Articles with similar content:

Colloidal Drug Delivery Systems: Current Status and Future Directions
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.32, 2015, issue 2
Goutam Rath, Tarun Garg, Amit Kumar Goyal
Liquid Biopsies in the Management of Bladder Cancer: Next-Generation Biomarkers for Diagnosis, Surveillance, and Treatment-Response Prediction
Critical Reviews™ in Oncogenesis, Vol.22, 2017, issue 5-6
Monica Cheng, Hristos Z. Kaimakliotis, Shaobo Zhang, Catherine R. Miller, Antonio Lopez-Beltran, Michael O. Koch, Yu Yang, Rodolfo Montironi, Liang Cheng
Targeted Breast Cancer Nanotherapeutics: Options and Opportunities with Estrogen Receptors
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.29, 2012, issue 5
Rishi Paliwal, Govind P Agrawal, Shivani Rai Paliwal, Suresh P. Vyas
Neural Tissue Engineering and Biohybridized Microsystems for Neurobiological Investigation In Vitro (Part 1)
Critical Reviews™ in Biomedical Engineering, Vol.39, 2011, issue 3
D. Kacy Cullen, Jelena Vukasinovic, Michelle C. LaPlaca, Varadraj N. Vernekar, John A. Wolf
Molecular Networks in Drug Discovery
Critical Reviews™ in Biomedical Engineering, Vol.38, 2010, issue 2
John Kenneth Morrow, Longzhang Tian, Shuxing Zhang